Pathios Therapeutics raised $25m in Series B funding from Bristol Myers Squibb, Canaan and Brandon Capital.

Biotech Health services Manufacturing

Investments

07 April 2024

Pathios Therapeutics (company)

Biotech Health services Manufacturing

Total investments received (USD): 38.2m

Round value (USD): 25m

Round investors: Brandon Capital Partners Bristol-Myers Squibb Canaan Partners

Industry: Biotech Health services Manufacturing

Biotech Health services Manufacturing Pharma

Investments 02 October 2024

Biotech Health services Manufacturing

Investments 03 September 2024

Biotech Health services Pharma

Investments 03 September 2024

Biotech Health services Manufacturing

Investments 19 July 2024

Biotech Health services Pharma

Investments 13 June 2024